Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eastman Chemical (EMN) Other financing activities (2017 - 2025)

Historic Other financing activities for Eastman Chemical (EMN) over the last 9 years, with Q4 2025 value amounting to $2.0 million.

  • Eastman Chemical's Other financing activities fell 8461.54% to $2.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$12.0 million, marking a year-over-year decrease of 14444.44%. This contributed to the annual value of -$12.0 million for FY2025, which is 14444.44% down from last year.
  • According to the latest figures from Q4 2025, Eastman Chemical's Other financing activities is $2.0 million, which was down 8461.54% from -$1.0 million recorded in Q3 2025.
  • Over the past 5 years, Eastman Chemical's Other financing activities peaked at $22.0 million during Q1 2021, and registered a low of -$19.0 million during Q1 2023.
  • Moreover, its 5-year median value for Other financing activities was -$1.0 million (2023), whereas its average is $666666.7.
  • In the last 5 years, Eastman Chemical's Other financing activities soared by 90000.0% in 2021 and then tumbled by 80000.0% in 2025.
  • Eastman Chemical's Other financing activities (Quarter) stood at -$3.0 million in 2021, then changed by 0.0% to -$3.0 million in 2022, then soared by 66.67% to -$1.0 million in 2023, then surged by 1400.0% to $13.0 million in 2024, then tumbled by 84.62% to $2.0 million in 2025.
  • Its Other financing activities was $2.0 million in Q4 2025, compared to -$1.0 million in Q3 2025 and -$4.0 million in Q2 2025.